Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shen Huang is a Traditional Chinese Medicine (TCM) formulation, typically prepared as an ointment or powder, used for the treatment of postoperative ileus (POI). Developed and studied by the Traditional Chinese Medicine Hospital of Zhejiang Province, it is applied topically to the umbilicus (umbilical application) to promote the recovery of gastrointestinal function. The formulation is specifically indicated for patients presenting with "qi stagnation and blood stasis" patterns. It typically contains ingredients such as *Radix et Rhizoma Rhei* (Rhubarb) and *Radix Salviae Miltiorrhizae* (Danshen), which are thought to stimulate intestinal peristalsis, improve local blood circulation, and reduce inflammatory responses in the gut.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shen huang.